Publications by authors named "Beverly L Falcon"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

8,066

Total Likes

903

Extended Reach

3,576,109

Social Features

227
T
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
Louis J Aronne, Deborah Bade Horn, Carel W le Roux, Wayne Ho, Beverly L Falcon, Elisa Gomez Valderas, Sagar Das, Clare J Lee, Leonard C Glass, Cagri Senyucel

N Engl J Med· July 2025

Videos about Article: user user user 4

7 13 5 207 14 539 5

View All Article and Social Media Activity
I
Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition.
Anthony S Fischl, Xiaoen Wang, Beverly L Falcon, Rowena Almonte-Baldonado, Diane Bodenmiller

Mol Cancer Ther· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors.
Bruce W Konicek, Andrew R Capen, Kelly M Credille, Philip J Ebert, Beverly L Falcon

Oncotarget· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma.
Caitlin D Lowery, Alle B VanWye, Michele Dowless, Wayne Blosser, Beverly L Falcon

Clin Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents.
Beverly L Falcon, Sudhakar Chintharlapalli, Mark T Uhlik, Bronislaw Pytowski

Pharmacol Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal-Based Signatures for the Classification of Gastric Cancer.
Mark T Uhlik, Jiangang Liu, Beverly L Falcon, Seema Iyer, Julie Stewart

Cancer Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An in vitro cord formation assay identifies unique vascular phenotypes associated with angiogenic growth factors.
Beverly L Falcon, Michelle Swearingen, Wendy H Gough, Linda Lee, Robert Foreman

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-content multiplexed tissue imaging and quantification for cancer drug discovery.
Beverly L Falcon, Julie Stewart, Scharri Ezell, Jeff Hanson, John Wijsman

Drug Discov Today· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition.
Beverly L Falcon, Belinda O'Clair, Don McClure, Glenn F Evans, Julie Stewart

J Hematol Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor-B.
Beverly L Falcon, Kristian Pietras, Jeyling Chou, Debbie Chen, Barbara Sennino

Am J Pathol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors.
Beverly L Falcon, Sharon Barr, Prafulla C Gokhale, Jeyling Chou, Jennifer Fogarty

Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2-neutralizing peptibody.
Angela Coxon, James Bready, Hosung Min, Stephen Kaufman, Juan Leal

Mol Cancer Ther· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth.
Hiroya Hashizume, Beverly L Falcón, Takashi Kuroda, Peter Baluk, Angela Coxon

Cancer Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.
Beverly L Falcón, Hiroya Hashizume, Petros Koumoutsakos, Jeyling Chou, James V Bready

Am J Pathol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.
Barbara Sennino, Beverly L Falcón, Dilara McCauley, Tom Le, Thomas McCauley

Cancer Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin II type 2 receptor-mediated gene expression profiling in human coronary artery endothelial cells.
Beverly L Falcón, Shereeni J Veerasingham, Colin Sumners, Mohan K Raizada

Hypertension· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension.
Beverly L Falcón, Jillian M Stewart, Erick Bourassa, Michael J Katovich, Glenn Walter

Physiol Genomics· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis